scispace - formally typeset
X

Xianxian Yao

Researcher at Fudan University

Publications -  12
Citations -  659

Xianxian Yao is an academic researcher from Fudan University. The author has contributed to research in topics: Photothermal therapy & Drug delivery. The author has an hindex of 7, co-authored 11 publications receiving 278 citations. Previous affiliations of Xianxian Yao include Shenzhen University.

Papers
More filters
Journal ArticleDOI

Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors.

TL;DR: In this article, the authors fused red blood cell membrane together with MCF-7 membrane and fabricated an erythrocyte-cancer (RBC-M) hybrid membrane-camouflaged melanin nanoparticle platform for enhancing therapeutic efficacy of photothermal therapy (PTT).
Journal ArticleDOI

Multifunctional nanoplatform for photoacoustic imaging-guided combined therapy enhanced by CO induced ferroptosis.

TL;DR: The generated CO molecules successfully increase cancer cell sensitivity to chemotherapeutics by the ferroptosis pathway and demonstrates high treatment efficacies in vitro and in vivo by combination of chemotherapy, photothermal therapy and gas therapy.
Journal ArticleDOI

Photocatalysis-mediated drug-free sustainable cancer therapy using nanocatalyst.

TL;DR: In this article, a Z-scheme SnS1.68-WO2.41 nanocatalyst is developed to achieve near infrared (NIR)-photocatalytic generation of oxidative holes and hydrogen molecules for realizing combined hole/hydrogen therapy by the drug-free therapeutic strategy.
Journal ArticleDOI

Metal-Organic Framework Nanoparticles with Near-Infrared Dye for Multimodal Imaging and Guided Phototherapy.

TL;DR: A one-pot approach to build the defect structure of a metal organic framework with near-infrared dye (cypate), which is based on the interaction between Fe3+ and carboxyl group of cypate molecules, to construct a multifunctional MOF, which can achieve multimodal imaging guided phototherapy and cancer phototherapy.
Journal ArticleDOI

Simvastatin induced ferroptosis for triple-negative breast cancer therapy

TL;DR: In this article, a novel ferroptosis nanomedicine was prepared by loading simvastatin (SIM) into zwitterionic polymer coated magnetic nanoparticles (Fe3O4@PCBMA) to improve the therapeutic effect of TNBC.